Jazz Pharmaceuticals
Price & Volume
Stats
See more52W Range | $99.06-$148.05 |
Market Cap | $7.4B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $4B |
Revenue Growth (YoY) | 7.5% |
Gross Profit (12 Mos) | $3.7B |
Diluted EPS | $8.65 |
News
See moreYahoo Finance • 9 hours ago
Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?
Yahoo Finance • 7 days ago
TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside
Yahoo Finance • 5 months ago
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
Yahoo Finance • 6 months ago
Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) The Top Stock With Improving Technical Ratings According To Piper Sandler?
About
CEO | Mr. Bruce C. Cozadd |
CFO | Mr. Philip L. Johnson |
Address | Waterloo Exchange, Dublin, Ireland, D04 E5W7 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,800 |
